Testing chromium in drinking water
Dionex has updated its methods to allow for more sensitive testing of toxic hexavalent chromium in drinking water.
Dionex has updated its methods to allow for more sensitive testing of toxic hexavalent chromium in drinking water. Concern about the dangers of hexavalent chromium in drinking water has been rising as the National Toxicology Program of the US Department of Health and Human Services has said that chromium-6 in drinking water shows evidence of carcinogenic activity. In addition, after the US EPA released a toxicological review of hexavalent chromium, the California Office of Environmental Health Hazard Assessment agency issued a new public health guideline setting the limit for chromate at 0.02 ppb in drinking water.
In response, Dionex has announced the release of Application Update 179: Sensitive Determination of Hexavalent Chromium in Drinking Water. According to the company this application update demonstrates a very sensitive ion chromatography method for determining hexavalent chromium at the proposed California level of 0.02 μg/L. Using the company’s 2 mm IonPac AG7 guard and AS7 analytical columns, the method appropriately reduces the flow-rates and reaction coil volume.
For more information visit www.dionex.com
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
